Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Middlesex Gases does not conduct clinical trials but supplies high-purity specialty, medical, and cryogenic gases to the life sciences, biotechnology, healthcare, research institutions, and industrial customers across New England. The company operates three fill plants with state-of-the-art labs for custom-blend specialty gases and FDA-approved medical CO₂. It also manufactures dry ice in-house. Approximately 85% of its business serves the life sciences/biotech sector. Services include gas system design/installations for labs/facilities; on-site quality analysis; safety training; remote cylinder monitoring; e-commerce ordering/integration; lab audits. The company remains independently owned after more than seven decades of operation. No pipeline/programs as it does not develop therapeutics. ISO/IEC 17025 Accredited. Celebrated its 75th anniversary in August 2024. Key clients include biotech/life science companies throughout Southern New England. Offers annual rebate incentives for high-volume MassBio members. Provides turn-key solutions for MicroBulk/Bulk applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Middlesex Gases.